Cecilia Low Wang, MD
Professor, Medicine-Endocrinology/Metabolism/Diabetes

Professional Titles

• Director, Glucose Management Team, UCH
• Clinician-Scientist, CPC Clinical Research
• Program Director, CU Diabetes Fellowship Training Program

Research Interests

Teaching

Publications

• Samson SL, Vellanki P, Blonde L, Christofides EA, Galindo RJ, Hirsch IB, Isaacs SD, Izuora KE, Low Wang CC, Twining CL, Umpierrez GE, Valencia WM. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update. Endocr Pract. 2023 May;29(5):305-340. PubMed PMID: 37150579
• Mubeen F, Low Wang CC, Al Maradni A, Shivaswamy V, Sadhu AR. Digital Health and Shared Decision-Making in Diabetes Care - A Survey Initiative in Patients and Clinicians. Endocr Pract. 2023 Jul;29(7):538-545. PubMed PMID: 37178788
• Sirlanci M, Levine ME, Low Wang CC, Albers DJ, Stuart AM. A simple modeling framework for prediction in the human glucose-insulin system. Chaos. 2023 Jul 1;33(7). PubMed PMID: 37486667
• Galindo RJ, Trujillo JM, Low Wang CC, McCoy RG. Advances in the management of type 2 diabetes in adults. BMJ Med. 2023;2(1):e000372. PubMed PMID: 37680340
• Wang Y, Stroh JN, Hripcsak G, Low Wang CC, Bennett TD, Wrobel J, Der Nigoghossian C, Mueller SW, Claassen J, Albers DJ. A methodology of phenotyping ICU patients from EHR data: High-fidelity, personalized, and interpretable phenotypes estimation. J Biomed Inform. 2023 Dec;148:104547. PubMed PMID: 37984547
• Low Wang CC, Seggelke SA, McDermott MT, Reusch JEB. Chapter 2: Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance. In Diabetes and COVID-19: Considerations and Clinical Management (Springer; ed. Alyson K Myers). 2023.
• Zahalka S, Rushakoff R, Low Wang CC. Chapter 27: Diabetes and Enteral Nutrition in the Hospital Setting. In Diabetes Management in Hospitalized Patients: A Comprehensive Clinical Guide. (Springer Vancouver; ed. Rifka Schulman-Rosenbaum). 2023. ISBN 978-3-031-44647-4.
• Low Wang CC, Alyson Myers, Chase Hendrickson. Endocrine Feedback Loop (Endocrine Society’s journal club podcast series) discussing “Glycemic Gap Predicts Mortality in a Large Multicenter Cohort Hospitalized With COVID-19” by McDonnell ME, et al, J Clin Endocrinol Metab 2023;108(3):718-725. EFL036: https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series/efl036-the-glycemic-gap-in-hospitalized-patients-with-covid. Aired April 20, 2023.
• Patel H, Robbins E, Hammond K, Raffel K, Low Wang CC, Thompson E. Sweet Work: Reducing Hypoglycemia Events in the Hospital. Virtual UCHealth Patient Safety Conference, Aurora, CO. March 16, 2023.
• Low Wang CC, Estacio RO, Coronel-Mockler S, Flattery N, McKenzie A, Harrison D, Bonaca MP. VICTOR-Pilot Study of a Virtual Dietary Intervention to Improve Diabetes and Cardiovascular Risk in Rural Communities – Primary Results. Endocrine Society Annual Meeting 2023. Session Number P14 Diabetes & Vascular Disease: Clinical Diabetes. Poster THU-254. J Endocr Soc 2023; 7(Suppl 1):bvad114.691.
• Mario E Canonico, CC Low Wang, E. Sebastian Debus, Mark Nehler, Manesh Patel, Sonia Anand, Warren Capell, Eva Muehlhofer, Lloyd Haskell, Scott D Berkowitz, Rupert Bauersachs, Marc P Bonaca. Impact of Low-Dose Rivaroxaban Plus Aspirin on Total Vascular Events in Fragile Patients With Peripheral Artery Disease: Insights From VOYAGER PAD. American Heart Association 2023 Annual Scientific Sessions. Circulation 2023;148:A16398.
• Govsyeyev N, Nehler MR, Low Wang CC, Kavanaugh S, Hiatt WR, Long C, Jones WS, Fowkes FGR, Berger JS, Baumgartner I, Patel MR, Goodney PP, Beckman JA, Katona BG, Mahaffey KW, Blomster J, Norgren L, Bonaca MP. Etiology and Outcomes of Amputation in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial. J Vasc Surg 2022;75(2):660-670.e3. doi: 10.1016/j.jvs.2021.08.096. PMID: 34597783.
• McRae M, Low Wang CC. Macrovascular Complications. Prim Care: Clinics Office Pract 2022;49(2):255-273. doi: 10.1016/j.pop.2021.11.012. PMID:35595481.
• Brooks D, Schulman-Rosenbaum R, Griff M, Lester J, Low Wang CC. Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review. Endocr Pract 2022;28(11):1166-1177. Doi: 10.1016/j.eprac.2022.07.014. PMID: 35940469
• Griff M, Crawley S, Rowland A, Seggelke S, Hawkins RM, Grafals M, Low Wang CC. Diabetes management at the time of renal transplantation. American Diabetes Association’s 82nd Scientific Sessions 2022. New Orleans, Louisiana. Poster 1293-P. Category 19: Transplantation.
• Seggelke SA, Griff M, Crawley S, Rowland A, Hawkins RM, Low Wang CC. Dysglycemia in patients without diabetes after renal transplantation. American Diabetes Association’s 82nd Scientific Sessions 2022. New Orleans, Louisiana. Poster 928-P. Category 13-B Health Care Delivery—Quality Improvement.
• Low Wang CC, Chong T, Moore G, Kafka R, Miller-Sarmento A, Trinh S, Miller A, Carter J, Mathes D, Freed B. Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers. DFCon 2022 - 22nd edition of the Interdisciplinary Global Diabetic Foot Conference. Los Angeles, California. Poster 44.
• Shubrook JH, Ramirez BF, Healy AM, Salzberg L, Ahmed S, Feinberg H, Schutta M, Schwartz FL, Low Wang CC. Primary Care Diabetes Fellowship Programs: Developing National Standards. Clin Diabetes. 2021 Jan;39(1):88-96. PubMed PMID: 33551558
• Govsyeyev N, Nehler MR, Low Wang CC, Kavanagh S, Hiatt WR, Long C, Jones WS, Fowkes FGR, Berger JS, Baumgartner I, Patel MR, Goodney PP, Beckman JA, Katona BG, Mahaffey KW, Blomster J, Norgren L, Bonaca MP. Etiology and Outcomes of Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. J Vasc Surg. 2021 Sep 28. [Epub ahead of print] PubMed PMID: 34597783
• Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clin Diabetes. 2021 Apr;39(2):228-232. PubMed PMID: 33986579
• Draznin B, Sadhu A, Schutta M, Ramirez BF, Polsky S, Shubrook JH, Low Wang CC. Authors' Reply: Improved Access to Quality Diabetes Care in the United States: Where Do We Go From Here?. Endocr Pract. 2021 Jul;27(7):760-761. PubMed PMID: 33940181
• Draznin B, Sadhu A, Schutta M, Ramirez BF, Polsky S, Shubrook JH, Low Wang CC. The Diabetes Epidemic and Diabetes Fellowships for Primary Care Physicians. Endocr Pract. 2021 Jun;27(6):636-637. PubMed PMID: 33757910
• Shubrook JH, Ramirez BF, Healy AM, Salzberg L, Ahmed S, Feinberg H, Schutta M, Schwartz FL, Low Wang CC. Primary Care Diabetes Fellowship Programs: Developing National Standards. Clin Diabetes. 2021 Jan;39(1):88-96. PubMed PMID: 33551558
• Hawkins RM, Adair WB, Gibbs J, Vinh J, Low Wang CC. Part 8, Chapter 42: Transient Severe Insulin Resistance in COVID-19 and Prediabetes. In Diabetes in Practice – Case Studies with Commentary. (ed.) Draznin B. Alexandria: American Diabetes Association, 2021.
• Low Wang CC. Part 8, Chapter 47: Coincidence or Consequence? A Case of Type 1 Diabetes with Worsening Neuropathy. In Diabetes in Practice – Case Studies with Commentary. (ed.) Draznin B. Alexandria: American Diabetes Association, 2021.
• Low Wang CC, McRae M. A commentary on: Liraglutide Hospital Discharge Trial: A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide versus Glargine Insulin for the Management of Patients with Type 2 Diabetes After Hospital Discharge. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/liraglutide-hospital-discharge-trial/114021/65/8/1. Accessed March 12, 2021.
• Low Wang CC. A commentary on: A Randomised Controlled Trial Comparing Insulin Degludec U100 and Glargine U100 for the Inpatient Management of Patients with Type 2 Diabetes. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/insulin-degludec-u100-vs-glargine-u100-for-inpatient-type-2-diabetes-management/123568/65/8/1. Accessed September 29, 2021.
• Hawkins RM, Seggelke S, Gibbs J, Lindsay M, Low Wang CC. Glycemic Control in Hospitalized Patients Receiving Enteral Nutrition. American Diabetes Association 81st Scientific Sessions 2021 (virtual). Poster #2021-A-5827-Diabetes. Diabetes 2021;70(Supplement 1):825-P. https://doi.org/10.2337/db21-825-P.
• Low Wang CC, Nehler M, Lloyd Haskell, Scott D Berkowitz, E. Sebastian Debus, Rupert Bauersachs, Marc P Bonaca. Risk Profile of Comorbid Diabetes and Benefit of Rivaroxaban in Patients with Critical Limb Ischemia: Insights from VOYAGER PAD. American Diabetes Association 81st Scientific Sessions 2021 (virtual). Poster #2021-LB-6784-Diabetes. Diabetes 2021
• Low Wang CC, E. Sebastian Debus, Mark Nehler, Manesh Patel, Sonia Anand, Warren Capell, Eva Muehlhofer, Lloyd Haskell, Scott D Berkowitz, Rupert Bauersachs, Marc P Bonaca, on behalf of the VOYAGER PAD investigators. Risk Profile and the Efficacy and Safety of Rivaroxaban in Fragile PAD Patients after Revascularization: Insights from VOYAGER PAD. European Society of Cardiology Congress 2021: Latest Science in Special Populations.
• Low Wang CC, E. Sebastian Debus, Mark Nehler, Manesh Patel, Sonia Anand, Matthew Jackson, Michael Szarek, Connie Hess, Warren Capell, Eva Muehlhofer, Lloyd Haskell, Scott D Berkowitz, Rupert Bauersachs, Marc P Bonaca, on behalf of the VOYAGER PAD investigators. Efficacy and Safety of Rivaroxaban in Patients with PAD with Concomitant Diabetes After Lower Extremity Revascularization. European Society of Cardiology Congress 2021: Latest Science in Special Populations.
• Bakris G, Rasouli N, Low Wang CC. Should metformin remain first-line therapy for type 2 diabetes? American Heart Association and American Diabetes Association Know Diabetes By Heart podcast. https://www.knowdiabetesbyheart.org/podcast/2020-episode-3-metformin-is-it-always-first/
• Reusch JEB. Featuring Low Wang CC. 2021 ADA General Highlights: GRADE Study, GIP/GLP-1 Receptor Agonists, Mental Health and Population Considerations in Diabetes, and More. VuMedi, 41 minutes.
• Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clin Diabetes. 2021 Apr;39(2):228-232. PubMed PMID: 33986579
• Seggelke SA, Ingram CI, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clin Diabetes published online Dec 22, 2020. https://doi.org/10.2337/cd20-0036.
• Low Wang CC. Commentary for www.PracticeUpdate.com on Diabetes Care article: A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/comparing-glargine-u300-and-glargine-u100-for-the-inpatient-management-of-patients-with-type-2-diabetes/98993/65/8/1. Accessed April 29, 2020
• Behan S, Low Wang CC, Hess C, Mulder H, Gutierrez A, Fowkes F, Baumgartner I, Berger J, Katona B, Mahaffey K, Norgren L, Blomster J, Jones S, Patel MR, Hiatt WR, Bonaca MP. Polyvascular disease with and without diabetes and the risk of adverse cardiovascular and limb events in the EUCLID trial. J Am Coll Cardiol 2020. 40. Vascular medicine: Non coronary arterial disease. 20-A-14515-ACC.
• Mayson SE, Haugen B, Low Wang CC. The Endocrinology Fellowship Thyroid/Neck Ultrasound Curriculum Innovations Project. 2020 AME Education Symposium. University of Colorado Anschutz Medical Campus, Aurora, CO.
• Zaman A, McDermott MT, Mansfield V, Low Wang CC. Mortality in Patients with Glucose Derangements after ICU Admission. American Diabetes Association’s 80th Scientific Sessions 2020 Virtual. 1611-P in category 16-F Epidemiology—Other.
• Govsyeyev N, Nehler MR, Low Wang CC, Kavanagh S, Hiatt WR, Long C, Jones WS, Fowkes FG, Berger JS, Patel MR, Katona B, Norgren L and Bonaca MP. Amputation in Patients With PAD With and Without Diabetes: Insights From the EUCLID Trial. American Heart Association Scientific Sessions 2020 Virtual. Circulation 2020;142(Suppl_3):Abstract 16512.
• Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?. Circulation. 2019 Apr 2;139(14):1741-1743. PubMed PMID: 30933621
• Hess CN, Low Wang CC, Hiatt WR. PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes. Annu Rev Med. 2018 Jan 29;69:133-145. PubMed PMID: 29095667
• Rogers RK, Hiatt WR, Patel MR, Shishehbor MH, White R, Khan ND, Bhalla NP, Jones WS, Low Wang CC. Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution. Vasc Med. 2018 Dec;23(6):513-522. PubMed PMID: 29629845
• Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. J Am Coll Cardiol. 2018 Dec 25;72(25):3274-3284. PubMed PMID: 30573030
• Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract. 2016 Dec;22(12):1401-1405. PubMed PMID: 27540884
• Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016 Jun 14;133(24):2459-502. PubMed PMID: 27297342
• Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract. 2014 Dec;20(12):1303-8. PubMed PMID: 25100383
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014 Jun;20(6):536-9. PubMed PMID: 24326004
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
• Wang CC, Adochio RL, Leitner JW, Abeyta IM, Draznin B, Cornier MA. Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism. 2013 Apr;62(4):595-603. PubMed PMID: 23174405
• Low Wang CC, Lu L, Leitner JW, Sarraf M, Gianani R, Draznin B, Greyson CR, Reusch JE, Schwartz GG. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. J Diabetes Complications. 2013 Jul-Aug;27(4):307-15. PubMed PMID: 23558108
• Low Wang CC, Draznin B. Practical approach to management of inpatient hyperglycemia in select patient populations. Hosp Pract (1995). 2013 Apr;41(2):45-53. PubMed PMID: 23680736
• Draznin B, Gilden J, Golden SH, Inzucchi SE, PRIDE investigators, Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Dungan KM, Falciglia M, Figaro MK, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013 Jul;36(7):1807-14. PubMed PMID: 23801791
• Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Low CC, Draznin B. Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocr Pract. 2013 Dec 10;:1-12. [Epub ahead of print] PubMed PMID: 24326004
• Draznin B, Gilden J, Golden SH, Inzucchi S, PRIDE Investigators. Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814. Diabetes Care. 2013 Dec;36(12):e220. PubMed PMID: 24265389
• Low Wang CC, Seggelke SA, McDermott MT, Reusch JEB. Chapter 2: Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance. In Diabetes and COVID-19: Considerations and Clinical Management (Springer; ed. Alyson K Myers).

Professional Memberships

• The Endocrine Society, Committee Member
• American Diabetes Association, Member
• American College of Physicians (ACP), Fellow
• American Association of Clinical Endocrinology, Vice Chair, Disease State Network Oversight Committee